Department of Physiology, Center of Systems Molecular Medicine, Medical College of Wisconsin, Milwaukee.
Hypertension. 2021 Aug;78(2):270-281. doi: 10.1161/HYPERTENSIONAHA.121.14536. Epub 2021 Jun 28.
The field of microRNA research has evolved from studies aiming to gauge the importance of microRNAs to those focusing on understanding a subset of specific microRNAs that have emerged as potent regulators of molecular systems and pathophysiological conditions. In this article, we review the molecular features and regulation of miR-204 and the growing body of evidence for an important role of miR-204 in the regulation of cardiovascular and renal physiology and pathophysiological processes. miR-204 exhibits a highly tissue-specific expression pattern, and miR-204 abundance is regulated by several transcriptional and posttranscriptional mechanisms. Strong evidence supports a role for miR-204 in attenuating pulmonary arterial hypertension and hypertensive and diabetic renal injury while promoting hypertension and endothelial dysfunction in a wide range of model systems. miR-204 may influence these disease processes by targeting several biological pathways in a tissue-specific manner. miR-204 is dysregulated in patients with cardiovascular and renal diseases. The unequivocal functional roles and clear clinical relevance indicate that miR-204 is a high-value microRNA in cardiovascular and renal diseases.
微小 RNA 研究领域已经从旨在评估微小 RNA 重要性的研究发展到专注于理解作为分子系统和病理生理状况的有效调节剂而出现的特定微小 RNA 亚类的研究。在本文中,我们回顾了 miR-204 的分子特征和调控,以及越来越多的证据表明 miR-204 在调节心血管和肾脏生理学和病理生理过程中的重要作用。miR-204 表现出高度组织特异性的表达模式,miR-204 的丰度受几种转录和转录后机制的调节。大量证据表明,miR-204 在减轻肺动脉高压和高血压及糖尿病肾损伤方面发挥作用,同时在广泛的模型系统中促进高血压和内皮功能障碍。miR-204 可能通过以组织特异性的方式靶向几种生物学途径来影响这些疾病过程。miR-204 在心血管和肾脏疾病患者中失调。明确的功能作用和明显的临床相关性表明,miR-204 是心血管和肾脏疾病中有价值的微小 RNA。